A Phase 1, Open-label, Randomized, Single Dose, Crossover Study Evaluating The Pharmacokinetics Of Epoetin Following Administration Of Epoetin Hospira Multiple Dose Vial (MDV) Product Compared To Epoetin Hospira Single Dose Vial (SDV) Product As Subcutaneous Injection To Normal Healthy Subjects
Phase of Trial: Phase I
Latest Information Update: 02 Feb 2018
At a glance
- Drugs Epoetin zeta (Primary)
- Indications Anaemia
- Focus Pharmacokinetics
- Sponsors Pfizer
- 30 Jan 2018 Planned primary completion date changed from 1 May 2018 to 11 May 2018.
- 30 Jan 2018 Status changed from not yet recruiting to recruiting.
- 29 Jan 2018 Planned End Date changed from 1 May 2018 to 11 May 2018.